- Research article
- Open Access
Functional distribution of Ca2+-coupled P2 purinergic receptors among adrenergic and noradrenergic bovine adrenal chromaffin cells
BMC Neuroscience volume 8, Article number: 39 (2007)
Adrenal chromaffin cells mediate acute responses to stress through the release of epinephrine. Chromaffin cell function is regulated by several receptors, present both in adrenergic (AD) and noradrenergic (NA) cells. Extracellular ATP exerts excitatory and inhibitory actions on chromaffin cells via ionotropic (P2X) and metabotropic (P2Y) receptors. We have taken advantage of the actions of the purinergic agonists ATP and UTP on cytosolic free Ca2+ concentration ([Ca2+]i) to determine whether P2X and P2Y receptors might be asymmetrically distributed among AD and NA chromaffin cells.
The [Ca2+]i and the [Na+]i were recorded from immunolabeled bovine chromaffin cells by single-cell fluorescence imaging. Among the ATP-sensitive cells ~40% did not yield [Ca2+]i responses to ATP in the absence of extracellular Ca2+ (Ca2+o), indicating that they expressed P2X receptors and did not express Ca2+- mobilizing P2Y receptors; the remainder expressed Ca2+-mobilizing P2Y receptors. Relative to AD-cells approximately twice as many NA-cells expressed P2X receptors while not expressing Ca2+- mobilizing P2Y receptors, as indicated by the proportion of cells lacking [Ca2+]i responses and exhibiting [Na+]i responses to ATP in the absence and presence of Ca2+o, respectively. The density of P2X receptors in NA-cells appeared to be 30–50% larger, as suggested by comparing the average size of the [Na+]i and [Ca2+]i responses to ATP. Conversely, approximately twice as many AD-cells expressed Ca2+-mobilizing P2Y receptors, and they appeared to exhibit a higher (~20%) receptor density. UTP raised the [Ca2+]i in a fraction of the cells and did not raise the [Na+]i in any of the cells tested, confirming its specificity as a P2Y agonist. The cell density of UTP-sensitive P2Y receptors did not appear to vary among AD- and NA-cells.
Although neither of the major purinoceptor types can be ascribed to a particular cell phenotype, P2X and Ca2+-mobilizing P2Y receptors are preferentially located to noradrenergic and adrenergic chromaffin cells, respectively. ATP might, in addition to an UTP-sensitive P2Y receptor, activate an UTP-insensitive P2Y receptor subtype. A model for a short-loop feedback interaction is presented whereby locally released ATP acts upon P2Y receptors in adrenergic cells, inhibiting Ca2+ influx and contributing to terminate evoked epinephrine secretion.
Adrenal chromaffin cells secrete norepinephrine and the stress-related hormone epinephrine in response to acetylcholine output from splanchnic nerve terminals. Its function is modulated by other transmitters and mediators released from either nerve terminals, adjacent cells or the cells themselves (for review see ). Among these regulators is ATP, which is co-released with transmitters and catecholamines since it is present in large amounts in secretory vesicles [2, 3]. It has long been known that extracellular ATP exerts multiple regulatory actions on catecholamine secretion from either whole adrenal glands or isolated chromaffin cells. Indeed, ATP evokes secretion in a Ca2+-dependent manner [4–8]. There are also reports showing that ATP and other ATP receptor agonists inhibit voltage-sensitive Ca2+ channels (via Gi/Go proteins) and inhibit depolarization-evoked catecholamine release [4, 9–14]. These channels are an essential component of the stimulus-secretion coupling cascade in chromaffin cells .
Historically, recognition of the two major chromaffin cell phenotypes (epinephrine-secreting or adrenergic, hereby referred to as AD-cells, and norepinephrine-secreting or noradrenergic, NA-cells) was based on morphological differences, secretory specificity of purified preparations and, later, on immunocytochemical labeling involving the use of antibodies against enzymes related to catecholamine biosynthesis . AD- and NA-cells appear to be differentially regulated by various transmitters or mediators (e.g. NO, histamine, angiotensin II and opioid peptides), and there is immunocytochemical and other evidence that some of its receptors are differentially distributed among both cell subtypes [17–22]. We have also provided functional and pharmacological evidence that chromaffin cell subpopulations express distinct ATP receptor subtypes, i.e. uridine 5'-triphosphate (UTP)-sensitive metabotropic receptors and suramin-blockable ionotropic receptors coupled to Ca2+ influx [7, 23]. It remains however unknown whether specific purinoceptor subtypes are asymmetrically distributed among AD- and NA-cells. This is an important issue, since it may shed light on the mechanisms regulating acute stress responses in superior organisms.
P2X receptors are Ca2+-permeable and provide an important Ca2+ influx pathway, both in neurons and other cell types (for review see ). The metabotropic (P2Y) purinoceptors are classical 7-transmembrane domain receptors coupled to either Gq/11 or Gi/o proteins and, predominantly, to Ca2+ release from intracellular stores, with at least eight known subtypes (for review see [24–26]).
Expression of P2Y2 and P2Y12 (formerly known as P2YADP or P2T) purinoceptors in rat chromaffin cells was suggested by immunocytochemistry and [35S]GTPγS autoradiography studies on adrenal medulla sections [27, 28]. Ennion et al.  demonstrated the presence of Gi/o-linked, adenine nucleotide-specific P2Y12 receptors in bovine chromaffin cells; in addition, the authors suggested the presence of an as yet unidentified UTP-sensitive, Gi/o-coupled P2Y receptor. Activation of both receptor subtypes inhibits voltage-sensitive Ca2+ channels and exocytosis [10, 13]. In contrast to the putative UTP-sensitive receptor, P2Y12 receptors in chromaffin cells are seemingly uncoupled to Ca2+ release from intracellular stores .
We have previously shown that ATP and UTP, at saturating concentrations, evoke rises in cytosolic free Ca2+ concentration ([Ca2+]i) of similar amplitude in a subpopulation of bovine chromaffin cells lacking P2X receptors . These nucleotides are seemingly equipotent for the Ca2+ mobilizing P2Y receptors, as suggested by [Ca2+]i studies in the absence of external Ca2+ . Both characteristics are consistent with UTP receptors (P2Y2 and/or P2Y4 ) playing a major role in the ATP responses under conditions where Ca2+ does not enter cells via ATP-gated channels. Thus, UTP appears to be the agonist of choice for monitoring the action of Ca2+-mobilizing P2Y receptors in bovine chromaffin cells. In contrast, 2-methylthioadenosine 5'-triphosphate (2-MeSATP), formerly thought to behave as a specific P2Y agonist, activates selected P2X and P2Y receptor subtypes in different cell types . (It is actually specific for P2X receptors in guinea-pig [31, 32] and bovine chromaffin cells .)
In this work, we have used ATP and UTP as purinergic agonists to investigate the distribution of Ca2+-coupled P2X and P2Y receptors among adrenergic and noradrenergic bovine chromaffin cells by single-cell fluorescence imaging. We found that, although neither of the major purinoceptor types can be ascribed to a particular cell phenotype, P2X and Ca2+-mobilizing P2Y receptors are preferentially located to noradrenergic and adrenergic chromaffin cells, respectively.
Identification of chromaffin cell phenotypes
N-phenyl ethanolamine N-methyl transferase (PNMT) is a specific enzyme for epinephrine biosynthesis; tyrosine hydroxylase (TH) is the rate-limiting enzyme for catecholamine biosynthesis. Thus, PNMT marks AD-cells and its absence in TH+ cells indicates that TH+/PNMT- cells are NA-cells. Fig. 1A and 1B depicts a typical immunocytochemical identification of chromaffin cells using anti-TH and anti-PNMT antibodies. A labeling index, scaled to the 0–255 range of an 8-bit image, was calculated bit-by-bit for each cell in a field by taking the ratio of background-corrected rhodamine fluorescence (indicative of PNMT expression) over background-corrected fluorescein fluorescence (indicative of TH expression). The labeling indices were used for the generation of pseudocolor images (Fig. 1C), thus allowing unambiguous identification of AD-cells (TH+/PNMT+; high index values, red) and NA-cells (TH+/PNMT-; low index values, green). An extra bonus of this analysis was to reveal that some cells actually gathered in small clusters (mostly 2 or 3 cells) displaying both phenotypes.
A fraction of the cells exhibited a yellowish or less marked red or green pseudocolor, suggesting a variable PNMT expression and, in some instances, raising doubts as to the identification of the respective phenotype. In order to resolve this issue, a frequency distribution histogram of the labeling index was constructed (Fig. 1D). Most of the cells fell at the extreme edges of the histogram and could, therefore, be clearly identified as either AD- or NA-cells. In order to set appropriate upper and lower threshold levels for error detection, a gamma distribution function was fitted to each side of the histogram (P = 0.005, i.e. 1 out of 200 cells mis-identified). The resulting cut-off levels are delimited by the black box in the pseudocolor scale (Fig. 1C). Cells that fell within this region were considered to be either PNMT false positives or false negatives, being therefore discarded from further analysis. Through this analysis AD-cells and NA-cells were found to account for 41% and 59% of the whole chromaffin cell population under study, respectively.
ATP- and UTP-evoked [Ca2+]irises in chromaffin cell subtypes
[Ca2+]i changes evoked by ATP receptor agonists were monitored by digital fluorescence imaging of the F340/F380 fura-2 fluorescence ratio (ΔR). Only cells that displayed sizeable [Ca2+]i responses to acetylcholine nicotinic receptor agonists (nicotine or 1,1-dimethyl-4-phenylpiperazinium iodide, DMPP), established functional markers of chromaffin cells , were considered for the study. To this end, cells were perifused at the tail of the experiments with either 10 μM nicotine or 10 μM DMPP for brief periods of time. Cells that were part of small clusters were considered for the study, provided that they could be unambiguously distinguished from each other through a combination of immunofluorescence staining and [Ca2+]i responsiveness.
Typical pseudocolor fura-2 fluorescence images are depicted in Fig. 2(A–C), together with the respective immunostaining identification (labeling index in pseudocolor, D). Resting [Ca2+]i was generally low prior to stimulation (A). Challenging cells for 30 s with 100 μM ATP in presence of extracellular calcium (Ca2+o) elicited sizeable, albeit variable peak [Ca2+]i responses from a large pool of chromaffin cells (B). It is noteworthy that some cells either did not respond to ATP or displayed faint responses. These were, for the most part, fully responsive to DMPP or nicotine. It should be emphasized that the concentration of ATP used to stimulate the cells throughout this work (100 μM) is one order of magnitude higher than the minimal concentration necessary to elicit maximal [Ca2+]i responses, i.e. 10 μM .
There was no apparent differentiation amongst chromaffin cell subtypes with respect to ATP responsiveness in presence of Ca2+o. Representative time courses of [Ca2+]i changes for selected chromaffin cells are depicted in Fig. 2E, showing that ATP evoked fast [Ca2+]i rises followed by decay toward a plateau regardless of whether the cells were adrenergic (e.g. cells 1 and 2) or noradrenergic (e.g. cells 3 and 4).
Cells were perifused with EGTA-containing solutions ([Ca2+]o ~100 nM [7, 23]) and subjected shortly after to similar ATP pulses (middle traces in Fig. 2E, peak [Ca2+]i imaging in Fig. 2C). This protocol, which was designed to minimize calcium depletion of intracellular stores [7, 23]), was found in this study to cause extensive depletion in a residual fraction of cells only (see the [Ca2+]i/UTP experiments below). Cells either did not respond to ATP in the virtual absence of Ca2+o (e.g. cells 2 and 4) or displayed [Ca2+]i responses consisting of a rapid rise followed by a decay toward baseline (e.g. cells 1 and 3). This all-or-none response pattern appeared to be unrelated to the specific chromaffin cell phenotype. Cell 5 represents a chromaffin cell that failed to respond to ATP both in high and low Ca2+o.
Pooling the entire data from Fig. 2 and similar experiments showed that 66% of the whole chromaffin cell population examined (i.e. 392 in 590 cells) responded to ATP in presence of Ca2+o. Thus, 34% of the cells either lacked Ca2+-coupled ATP receptors or had non-functional ATP receptors. Forty two % of the cells displaying positive responses in presence of Ca2+o (163 in 392) lacked purinergic responses in the virtual absence of Ca2+o, suggesting that these cells expressed P2X purinergic receptors and did not express Ca2+-mobilizing P2Y receptors. Therefore, fifty eight % of the cells displaying positive responses in presence of Ca2+o were provided with Ca2+-mobilizing P2Y purinoceptors, as indicated by the proportion of cells displaying above-threshold ATP-evoked [Ca2+]i responses in the absence of Ca2+o. The adopted detection threshold level was a ΔR change of 0.2 (close to the maximal amplitude of the background noise or spurious fluctuations observed under basal conditions).
Phenotype-specific analysis of the data is provided in Fig. 3 in the form of frequency distribution histograms of peak ΔR responses to ATP. Both the AD- and NA-subpopulations contained a significant fraction of cells that either lacked Ca2+-coupled ATP receptors or had non-functional ATP receptors (39% and 29%, respectively), as depicted by the leftmost columns in the upper histograms. Twenty four % of AD-cells displaying positive responses in presence of Ca2+o (38 in 161) lacked purinergic responses in the virtual absence of Ca2+o; the respective figure for NA-cells was 54% (125 in 231 cells). Thus, the fraction of cells that expressed P2X receptors but did not express Ca2+-mobilizing P2Y receptors was more than the double in NA-cells relative to the AD-cell subpopulation. In turn, 76% of AD-cells displaying positive responses in presence of Ca2+o (123 in 161 cells) also responded in the virtual absence of Ca2+o; the respective figure for NA-cells was 46% (106 in 231 cells). Thus, the fraction of cells expressing Ca2+-mobilizing P2Y receptors was approximately 39% higher in the AD-subpopulation. Hence, although expression of P2X and Ca2+-mobilizing P2Y receptors cannot be assigned to specific chromaffin cell phenotypes, there appears to be an asymmetric distribution of these receptors amongst AD- and NA-cells, with the latter expressing significantly more P2X and less Ca2+-mobilizing P2Y receptors.
As also shown in Fig. 3 (upper histograms), the mean size of the peak ATP-evoked [Ca2+]i responses, recorded in presence of Ca2+o, was significantly higher for NA-cells compared to AD-cells (1.06 ± 0.53 vs. 0.90 ± 0.50, n = 161/231 cells; p < 0.005). Since these are probably mixed responses, reflecting activation of both P2 receptor types, the difference might be caused by a higher average density of P2X receptors, Ca2+-mobilizing P2Y receptors or both in NA-cells. Indeed, mean ΔR in presence of Ca2+o was also significantly higher for NA-cells that did not respond to ATP in the virtual absence of Ca2+o (1.02 ± 0.53 vs. 0.75 ± 0.44 for AD-cells, n = 38/125 cells; p < 0.005). This suggests that individual NA-cells might, on average, have a higher density of P2X receptors. With respect to P2Y receptors, the best possible approach is to compare the ΔR value distributions in the virtual absence of Ca2+o (lower histograms). Mean ΔR was 0.73 ± 0.37 (n = 123 cells) and 0.59 ± 0.30 (n = 106 cells) for AD- and NA-cells, respectively (significantly different, p < 0.005). This suggests that, on average and contrary to P2X receptors, individual AD-cells might have a higher density of Ca2+-mobilizing P2Y receptors.
The following experiments were designed to assess the [Ca2+]i responses of immunolabeled chromaffin cells to activation of UTP-sensitive receptors (henceforth designated "P2U receptors" for simplicity). Typical pseudocolor fura-2 fluorescence images are depicted in Fig. 4(A–C) , together with the respective immunostaining identification (D) and representative time courses of [Ca2+]i changes for selected chromaffin cells (E). As for ATP, applying brief pulses of 100 μM UTP in presence of Ca2+o elicited sizeable, albeit variable peak [Ca2+]i responses from both AD-cells (e.g. cells 1 and 2) and NA-cells (e.g. cells 3 and 4) (B and E). The predominant response pattern was a fast rise, followed by a slow decay which did not reach baseline by the end of the 30 s UTP challenge. The majority of cells displaying positive responses in presence of Ca2+o yielded sizeable, albeit somewhat diminished responses to the purinergic agonist in the virtual absence of Ca2+o, regardless of the respective phenotype. It is noteworthy that, under these conditions, the [Ca2+]i tended to decay toward baseline at a faster rate throughout agonist exposure. A few cells did not respond to UTP in the virtual absence of Ca2+o while yielding a sizeable response in its presence. It should be emphasized that the concentration of UTP used to stimulate the cells throughout this work (100 μM) evokes maximal [Ca2+]i responses from bovine chromaffin cells .
Pooling the entire data from Fig. 4 and similar experiments showed that 63% of the whole chromaffin cell population examined (i.e. 182 in 288 cells) responded to UTP in presence of Ca2+o, indicating that these cells expressed functional "P2U receptors". This figure is close to the fraction of chromaffin cells (66%) that have been shown to express functional ATP receptors in the former experiments where ATP was used as a purinergic agonist (Figs. 2 and 3). This was an unexpected finding, since UTP (admittedly a purinergic agonist specific for selected P2Y receptor subtypes) should probe a subset of the ATP-sensitive receptor subtypes. There are several possibilities to account for this apparent discrepancy. First, UTP might have ionotropic-like effects in chromaffin cells. Secondly, the integrity of P2X and/or P2Y receptors might be highly sensitive to the harshness of collagenase digestion (and therefore prone to undergo spurious changes from batch to batch). Finally, the cell pool used in the [Ca2+]i/UTP experiments might contain an exceedingly higher proportion of AD-cells (which express more P2Y receptors than NA-cells, see above). This proportion was indeed 59% (vs. 45% in the former [Ca2+]i/ATP experiments). The "UTP specificity" hypothesis is ruled out by the intracellular sodium experiments (see below).
Phenotype-specific analysis of the data using frequency distribution histograms (Fig. 5) shows that both the AD- and NA-subpopulations contained a significant fraction of cells that either lacked or had non-functional "P2U receptors" (38% and 34%, respectively), as depicted by the leftmost columns in the upper histograms.
Moreover, 93% of the AD-cells (97 in 104) displaying positive UTP responses in presence of Ca2+o also displayed detectable responses in the virtual absence of Ca2+o; the respective figure for NA-cells was 91% (71 in 78 cells). This indicates that subjecting the vast majority of cells to EGTA-containing solutions did not cause extensive depletion of internal Ca2+ stores.
As also shown in Fig. 5 (upper histograms), the mean size of the UTP-evoked [Ca2+]i responses, recorded in presence of Ca2+o, was not significantly different between AD- and NA-cells (0.85 ± 0.43 vs. 0.90 ± 0.49, n = 118/170 cells; p = 0.5). Nor was the mean size recorded in the virtual absence of Ca2+o (0.69 ± 0.37 and 0.68 ± 0.40 for AD- and NA-cells, respectively; n = 71/97 cells, p = 0.9; lower histograms). This suggests that, in contrast to the situation found for Ca2+ mobilizing P2Y receptors in the [Ca2+]i/ATP experiments, individual AD- and NA-cells might have a similar average density of "P2U receptors".
Subjecting AD-cells to EGTA-containing solutions reduced significantly (19%) the mean size of the UTP-evoked [Ca2+]i responses (0.69 ± 0.37 vs. 0.85 ± 0.43 for high Ca2+o; n = 97 cells, p < 0.005). A similar observation was made for NA-cells (0.68 ± 0.40 vs. 0.90 ± 0.49 for high Ca2+o, a 24% change; n = 71/118 cells, p < 0.0001). The simplest explanation for these differences is that reducing extracellular free Ca2+ to around 100 nM depleted intracellular Ca2+ stores by approximately 20% in both cell types.
[Na+]iresponses to purinergic agonists in chromaffin cell subtypes
The following experiments were designed to investigate the specificity of UTP as a P2Y receptor agonist in chromaffin cells, as well as to further assess the possibility that P2X receptors might be differentially distributed among AD- and NA-cells. When activated, these receptors allow for pronounced Na+ influx and concomitant increases in cytosolic free Na+ concentration ([Na+]i) , which in the present work were assessed by sodium-binding benzofuran isophthalate (SBFI) fluorescence imaging. The adopted detection threshold level was a ΔR change of 0.05.
Pseudocolor SBFI fluorescence images are depicted in Fig. 6(A–C), together with the respective immunostaining identification (D) and a representative time course of [Na+]i changes (E). ATP evoked rapid and sustained [Na+]i rises in a fraction of the cells (B and E), followed by a slow return toward basal levels (not depicted in the figure). Subsequent application of UTP failed to raise the [Na+]i in all cells tested (n = 749, C and E). Thus, activation of "P2U receptors" is not coupled to Na+ influx and UTP does not activate P2X receptors.
Only a fraction of the cells (21% AD-cells and 45% NA-cells) displayed positive responses to ATP ([Na+]i rises) according to the detection threshold level adopted; the remainder failed to respond, as depicted by the leftmost columns of the frequency distribution histograms (Fig. 6F). Moreover, the mean size of the ATP-evoked [Na+]i responses was significantly higher for NA-cells compared to AD-cells (0.15 ± 0.11 vs. 0.08 ± 0.04, n = 51/231 cells; p < 0.0001). It is noteworthy that the mean size of the ATP-evoked [Na+]i responses in AD-cells was just slightly above the detection threshold level. This reinforces the view that NA-cells might have a higher average density of P2X receptors.
A significant fraction of the chromaffin cell population used in this work (~30%) did not respond to ATP in presence of extracellular Ca2+, suggesting that these cells either lacked Ca2+-coupled purinergic receptors or that the existing receptors were rendered non-functional owing to enzymatic treatment. As revealed by the [Ca2+]i/ATP experiments, approximately 40% of the cells displaying functional purinoceptors expressed P2X receptors but did not express Ca2+-mobilizing P2Y receptors; approximately 60% yielded positive responses to ATP in the virtual absence of extracellular Ca2+, indicating that they expressed Ca2+-mobilizing P2Y receptors. Coexistence of P2X and P2Y receptors in a limited fraction of the latter cells cannot be ruled out, as suggested by an earlier study from our laboratory .
As revealed by the [Ca2+]i/ATP and [Na+]i experiments (which accounted for over 85% of the cells examined), relative to AD-cells more than the double of individual NA-cells expressed P2X receptors and did not express Ca2+-mobilizing P2Y receptors. Moreover, the density of P2X receptors in NA-cells appeared to be 30–50% larger, as suggested by comparing the average size of the [Ca2+]i and [Na+]i responses. Thus, although P2X receptors cannot be ascribed to a specific cell phenotype they are preferentially located to the NA-cell subpopulation. Conversely, by the same criteria approximately twice as many AD-cells expressed Ca2+-mobilizing P2Y receptors, and they appeared to exhibit a higher (~20%) receptor density. Hence, the distribution of Ca2+-mobilizing P2Y receptors is also asymmetric, with these receptors being preferentially located to the AD-cell subpopulation.
The cell pool used for the [Ca2+]i/UTP experiments (~15% of the cells examined in this study) displayed a disproportionately high fraction of cells expressing Ca2+-mobilizing P2Y receptors. This cannot be attributed to lack of specificity of UTP as a P2Y receptor agonist, as demonstrated by the [Na+]i experiments (UTP did not evoke Na+ influx in any of the cells tested). A possible explanation is that, compared to the [Ca2+]i/ATP experiments, the cell pool was somewhat enriched in AD-cells. Another plausible explanation is that P2X receptors might be more prone to damage during the collagenase-isolation procedure, thereby causing an artifactual and sporadic enrichment of functional P2Y receptors. It is noteworthy in this respect that, in several studies reporting an electrophysiological analysis of the modulatory effect of P2Y receptor activation on voltage-sensitive Ca2+ currents and exocytosis, extracellular ATP either failed to evoke inward currents and secretion or these effects were observed sporadically [4, 9–14] (but see others where clear-cut effects of P2X agonists have been observed [31, 32]). Nonetheless, the [Ca2+]i/UTP experiments were instrumental to assess the possibility that reducing extracellular Ca2+ to ~100 nM might cause extensive depletion of intracellular Ca2+ stores. This was not the case, as indicated by the residual number of cells that lost ATP responsiveness when exposed to EGTA-containing solutions.
Interestingly, the density of UTP-sensitive P2Y receptors did not vary with the chromaffin cell phenotype, as suggested by comparing the average size of the [Ca2+]i responses between AD- and NA-cells. Taking into account the homologous data from the [Ca2+]i/ATP experiments, which hinted at a higher Ca2+-mobilizing P2Y receptor density in AD-cells (see above), this suggests that ATP might, in addition to the "P2U receptor", activate an UTP-insensitive Ca2+-mobilizing P2Y receptor subtype in bovine chromaffin cells (see  for further evidence). This is not unlikely, as distinct P2Y subtypes coexist in neurons and other cells [24, 26, 36]. One possibility is the P2Y12 receptor reported by Ennion et al. , which however did not appear to be coupled to Ca2+ release from intracellular stores, at least under the stringent experimental conditions imposed by the authors. It is also noteworthy that Ennion et al. detected transcripts for P2Y1 receptors by RT-PCR analysis. Work is now in progress to identify the putative UTP-insensitive P2Y receptor.
The present finding that P2X receptors are preferentially expressed in noradrenergic bovine chromaffin cells agrees with earlier observations that ATP evokes the preferential, if not exclusive release of norepinephrine from chromaffin cell preparations [6, 23]. There is evidence that stimulated Ca2+ influx is strongly coupled to catecholamine release; in contrast, Ca2+ release from intracellular stores (a characteristic feature of most Gi/o- and Gq/11-coupled P2Y receptor subtypes ) appears to be loosely coupled to secretion [15, 23]. Activation of P2Y receptors is actually known to inhibit evoked neurotransmitter release, notably from sympathetic and noradrenergic brain neurons . The same holds for chromaffin cells, where P2Y receptor activation inhibits voltage-sensitive Ca2+ channels via Gi/Go proteins and, thus, depresses Ca2+-dependent exocytosis [4, 9–14]. Activation of P2Y receptors also inhibits catecholamine secretion downstream Ca2+ influx in rat chromaffin cells . Although the role for these modulations remains unclear, it has been suggested that they might be an essential component of an auto-inhibitory loop involving granule-stored ATP. Besides ATP other endogenous modulators (e.g. opioid peptides and catecholamines) have been involved in autocrine/paracrine interactions within the adrenal medulla [39–42].
Excessive release of epinephrine following an acute stress episode may cause irreversible damage of the myocardium and other dysfunctions, eventually leading to death. Not considering auto-inhibitory feedback loops related to cholinergic transmission, inhibitory transmitters released from nerve terminals within the adrenal medulla (e.g. opioid peptides, ATP and norepinephrine), inhibitory transmitters or mediators released from chromaffin cells (e.g. opioid peptides, norepinephrine, ATP and chromogranin A-derived fragments) or molecules arising from the degradation of any of these (e.g. adenosine via ectonucleotidases) are well suited to prevent that from occurring provided that the respective receptors are preferentially located at adrenergic chromaffin cells. The available evidence indicates that this likely is the case for ATP and opioid peptides. Indeed, the adrenergic cell subpopulation is enriched in P2Y (this work) and κ-opioid receptors . Furthermore, endogenous agonists for both receptors exert profound inhibitory actions on voltage-sensitive Ca2+ channels and exocytosis [4, 9, 10, 12–14, 40–44]. There is also compelling evidence for short-loop feedback inhibition of epinephrine release by norepinephrine (via α2C-adrenoceptors) .
In the light of the present results, we propose a mechanism (Fig. 7) whereby: 1) ATP is initially co-released from cholinergic nerve endings, facilitating norepinephrine release from NA-cells via fast P2X receptor-coupled channels; 2) ATP, co-released with both epinephrine and norepinephrine, acts upon P2Y receptors in AD-cells, inhibiting Ca2+ influx and contributing to terminate epinephrine secretion after a diffusion delay. This inhibition may be effected on voltage-sensitive Ca2+ channels directly by Gi/Go proteins or indirectly by specific PKC isoforms, as demonstrated by our laboratory . (As noted above, activation of P2Y receptors elicits Ca2+ release from intracellular stores which, however, does not evoke catecholamine secretion from bovine chromaffin cells. Secretion appears to occur from discrete exocytotic sites . Thus, the focal Ca2+ signal may dissipate to the extent that these sites are not activated. Ca2+ release from intracellular stores may nonetheless be relevant to modulate other cellular targets, including the nucleus.) Short-loop feedback inhibition of epinephrine release by activation of κ-opioid and α2-adrenergic receptors is also depicted in the model (Fig. 7). Finally, adenosine arising from the degradation of extracellular ATP may contribute to the inhibitory loop .
Although neither of the major purinoceptor types can be ascribed to a particular cell phenotype, P2X and Ca2+-mobilizing P2Y receptors are preferentially located to noradrenergic and adrenergic chromaffin cells, respectively. ATP might, in addition to an UTP-sensitive P2Y receptor, activate an UTP-insensitive P2Y receptor subtype. A model for a short-loop feedback interaction is presented whereby locally released ATP acts upon P2Y receptors in adrenergic cells, inhibiting Ca2+ influx and contributing to terminate epinephrine secretion evoked by splanchnic nerve stimulation.
Bovine adrenal glands were obtained from the local slaughterhouse and kept on ice during transportation. Adrenal medulla cells were isolated by collagenase digestion of the glands and purified on a Percoll density gradient essentially as described previously [49, 50]. The purified cell fraction thus obtained is enriched in chromaffin cells. Cells were cultured under a 5% CO2/95% air humidified atmosphere in a 1:1 mixture of Dulbecco's modified Eagle's medium (DMEM)/Ham's F-12 medium buffered with 15 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid (HEPES) and 25 mM NaHCO3, supplemented with 5% heat-inactivated fetal calf serum, penicillin (100 units/ml) and streptomycin (100 μg/ml) (Biological Industries, Beth Haemek, Israel). The cells were plated on grid-etched glass coverslips coated with poly-L-lysine. Cells were typically used between days 2 and 5 after plating.
The Ca2+-containing salt solution used in the imaging experiments had the following composition (mM): 140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 mM HEPES and 10 glucose (pH 7.4). In some experiments extracellular free [Ca2+] was buffered at 100 nM by mixing appropriate amounts of Ca2+ and EGTA, as described elsewhere .
[Ca2+]i and [Na+]iimaging
The coverslips containing the cells were washed in physiological saline supplemented with 1% bovine serum albumin (BSA). The cells were then loaded with either 2.5 μM fura-2/AM (the acetoxymethyl ester of fura-2, [Ca2+]i measurements ) or 10 μM SBFI ([Na+]i measurements ) for 45 min at 37°C in this medium, under a 95% O2/5% CO2 atmosphere. After loading, the coverslips were washed and maintained in BSA-containing solution at room temperature. The loaded cells were assayed within 90 min from the end of loading. Each coverslip was glued to the bottom of a small (approximately 100 μl) perifusion chamber and placed on the stage of a Nikon Diaphot inverted fluorescence microscope. The cells were continuously perifused (approximately 1.5 ml/min) with physiological saline at room temperature. The solution was fed into a four-way stopcock valve located near the recording chamber. The fluorescence changes were recorded using a multiple excitation MagiCal imaging system (Applied Imaging, U.K.), essentially as described . Briefly, chromaffin cells were alternately excited at 340 and 380 nm by means of a stepping filter wheel and the epifluorescence optics of the microscope. Emitted fluorescence collected with a 20× objective was driven to a Photonics Science SIT camera after passing through a 510 nm bandpass filter. Eight frames (approximately 100 ms exposure) were averaged to produce each image. Alternating excitation, image capture and processing were controlled by a single processor in the MagiCal system. Image analysis was performed with in-house and commercially available software. Essentially, background fluorescence at each wavelength (obtained from a field devoid of cells in each coverslip) was subtracted and fluorescence images ratioed on a pixel-by-pixel basis. Ratio data were stored as 8-bit pseudocolored images. A contour was drawn around each cell in a field and the averaged ratio value of pixels inside each contour evaluated at each time point, in order to obtain ratio vs. time plots for all cells.
Following the microfluorescence experiments the cells attached to the coverslips were fixed for 2 min in ice-cold acetone/methanol (1:1, v/v), and stored frozen (-20°C) until further processing. For immunolabeling the coverslips were thawed in acetone/methanol, washed in phosphate buffer saline (PBS) and blocked for 1 h with PBS containing 3% BSA, 1% normal goat serum (NGS) and 0.1% Triton X-100. The following primary antibodies were used for specific labeling of adrenergic chromaffin cells and all adrenergic + noradrenergic chromaffin cells: polyclonal rabbit anti-PNMT (1:1000, Affinity Research, Exeter, Devon, UK) and monoclonal mouse anti-TH (1:100, Boehringer Mannhein, Germany), respectively. Cells were incubated with primary antibodies for 1 h at 37°C, and washed in PBS containing 0.1% Triton X-100. Fluorescence labeling of AD-cells and the whole chromaffin cell population was carried out by incubating the cells for 1 h with the following secondary antibodies: TRITC (tetramethylrhodamine isothiocyanate)-conjugated anti-rabbit IgG and FITC (fluorescein isothiocyanate)-conjugated anti-mouse IgG at 1:200 (Sigma, St. Louis, MO, USA), respectively.
Immunocytochemical controls were prepared as described, omitting the primary antibodies and incubating the cells with 3% BSA instead. Thus, these controls assessed nonspecific binding of labeled secondary antibodies to sample structures. Immunofluorescence images were acquired by the MagiCal imaging system, using appropriate fluorescein and rhodamine filters (Omega Optical, Brattleboro, VT, USA). A quantitative labeling index (rhodamine/fluorescein fluorescence intensity ratio) was established to identify chromaffin cell subtypes (see above). As for the intracellular calcium and sodium experiments, ratioing immunofuorescence intensities was expected to cancel errors arising from heterogeneous illumination and other instrumental factors. The coverslips used in the experiments were grid-etched, so that single cell calcium and sodium responses could be assigned to particular chromaffin cells.
Data are presented as mean ± S.D. Statistical significance of differences was assessed by paired (within the same experiment) or unpaired (between experiments) Student's t-test; differences were considered significant at the 95% confidence level (P < 0.05). A gamma distribution function was used to fit the histogram in Fig. 1 (not shown); a lognormal distribution function was used to fit the skewed distribution histograms in Figs. 3, 5 and 6, skipping the data relative to the first bin (ΔR < 0.2 for Figs. 3 and 5 or ΔR < 0.05 for Fig. 6). Fitting the data to probability density functions was made with gnuplot  following the guidelines of the Statistical Engineering Division of the National Institute of Standards and Technology .
Fura-2/AM and SBFI were from Molecular Probes (Eugene, Ore., USA). ATP was from Boehringer (Mannheim, Germany). Unless otherwise specified, all other chemicals were from Sigma Chemical Co. (St. Louis, Mo., USA).
Aunis D, Langley K: Physiological aspects of exocytosis in chromaffin cells of the adrenal medulla. Acta Physiol Scand. 1999, 167: 89-97. 10.1046/j.1365-201x.1999.00580.x.
Douglas WW, Poisner AM: On the relation between ATP splitting and secretion in the adrenal chromaffin cell: extrusion of ATP (unhydrolysed) during release of catecholamines. J Physiol. 1966, 183: 249-256.
Rojas E, Pollard HB, Heldman E: Real-time measurements of acetylcholine-induced release of ATP from bovine medullary chromaffin cells. FEBS Lett. 1985, 185: 323-327. 10.1016/0014-5793(85)80931-5.
Diverse-Pierluissi M, Dunlap K, Westhead EW: Multiple actions of extracellular ATP on calcium currents in cultured bovine chromaffin cells. Proc Natl Acad Sci U S A. 1991, 88: 1261-1265. 10.1073/pnas.88.4.1261.
Kim KT, Westhead EW: Cellular responses to Ca2+ from extracellular and intracellular sources are different as shown by simultaneous measurements of cytosolic Ca2+ and secretion from bovine chromaffin cells. Proc Natl Acad Sci U S A. 1989, 86: 9881-9885. 10.1073/pnas.86.24.9881.
Lin LF, Bott MC, Kao LS, Westhead EW: ATP stimulated catecholamine secretion: response in perfused adrenal glands and a subpopulation of cultured chromaffin cells. Neurosci Lett. 1995, 183: 147-150. 10.1016/0304-3940(94)11136-7.
Castro E, Tome AR, Miras-Portugal MT, Rosario LM: Single-cell fura-2 microfluorometry reveals different purinoceptor subtypes coupled to Ca2+ influx and intracellular Ca2+ release in bovine adrenal chromaffin and endothelial cells. Pflugers Arch. 1994, 426: 524-533. 10.1007/BF00378530.
Reichsman F, Santos S, Westhead EW: Two distinct ATP receptors activate calcium entry and internal calcium release in bovine chromaffin cells. J Neurochem. 1995, 65: 2080-2086.
Lim W, Kim SJ, Yan HD, Kim J: Ca2+-channel-dependent and -independent inhibition of exocytosis by extracellular ATP in voltage-clamped rat adrenal chromaffin cells. Pflugers Arch. 1997, 435: 34-42. 10.1007/s004240050481.
Powell AD, Teschemacher AG, Seward EP: P2Y purinoceptors inhibit exocytosis in adrenal chromaffin cells via modulation of voltage-operated calcium channels. J Neurosci. 2000, 20: 606-616.
Hernandez-Guijo JM, Gandia L, Cuchillo-Ibanez I, Albillos A, Novalbos J, Gilsanz F, Larranaga E, de PR, Abad F, Garcia AG: Altered regulation of calcium channels and exocytosis in single human pheochromocytoma cells. Pflugers Arch. 2000, 440: 253-263.
Harkins AB, Fox AP: Activation of purinergic receptors by ATP inhibits secretion in bovine adrenal chromaffin cells. Brain Res. 2000, 885: 231-239. 10.1016/S0006-8993(00)02952-8.
Ennion SJ, Powell AD, Seward EP: Identification of the P2Y(12) receptor in nucleotide inhibition of exocytosis from bovine chromaffin cells. Mol Pharmacol. 2004, 66: 601-611. 10.1124/mol.104.000224.
Ulate G, Scott SR, Gonzalez J, Gilabert JA, Artalejo AR: Extracellular ATP regulates exocytosis in inhibiting multiple Ca(2+) channel types in bovine chromaffin cells. Pflugers Arch. 2000, 439: 304-314. 10.1007/s004240050944.
Burgoyne RD: Control of exocytosis in adrenal chromaffin cells. Biochim Biophys Acta. 1991, 1071: 174-202.
Moro MA, Lopez MG, Gandia L, Michelena P, Garcia AG: Separation and culture of living adrenaline- and noradrenaline-containing cells from bovine adrenal medullae. Anal Biochem. 1990, 185: 243-248. 10.1016/0003-2697(90)90287-J.
Oset-Gasque MJ, Vicente S, Gonzalez MP, Rosario LM, Castro E: Segregation of nitric oxide synthase expression and calcium response to nitric oxide in adrenergic and noradrenergic bovine chromaffin cells. Neuroscience. 1998, 83: 271-280. 10.1016/S0306-4522(97)00377-1.
Castro E, Gonzalez MP, Oset-Gasque MJ: Distribution of gamma-aminobutyric acid receptors in cultured adrenergic and noradrenergic bovine chromaffin cells. J Neurosci Res. 2003, 71: 375-382. 10.1002/jnr.10488.
Nunez L, De La Fuente MT, Garcia AG, Garcia-Sancho J: Differential Ca2+ responses of adrenergic and noradrenergic chromaffin cells to various secretagogues. Am J Physiol. 1995, 269: C1540-C1546.
Choi AY, Cahill AL, Perry BD, Perlman RL: Histamine evokes greater increases in phosphatidylinositol metabolism and catecholamine secretion in epinephrine-containing than in norepinephrine-containing chromaffin cells. J Neurochem. 1993, 61: 541-549.
Bunn SJ, Marley PD, Livett BG: The distribution of opioid binding subtypes in the bovine adrenal medulla. Neuroscience. 1988, 27: 1081-1094. 10.1016/0306-4522(88)90212-6.
Marley PD, Bunn SJ, Wan DC, Allen AM, Mendelsohn FA: Localization of angiotensin II binding sites in the bovine adrenal medulla using a labelled specific antagonist. Neuroscience. 1989, 28: 777-787. 10.1016/0306-4522(89)90022-5.
Castro E, Mateo J, Tome AR, Barbosa RM, Miras-Portugal MT, Rosario LM: Cell-specific purinergic receptors coupled to Ca2+ entry and Ca2+ release from internal stores in adrenal chromaffin cells. Differential sensitivity to UTP and suramin. J Biol Chem. 1995, 270: 5098-5106. 10.1074/jbc.270.10.5098.
Ralevic V, Burnstock G: Receptors for purines and pyrimidines. Pharmacol Rev. 1998, 50: 413-492.
Burnstock G: Historical review: ATP as a neurotransmitter. Trends Pharmacol Sci. 2006, 27: 166-176. 10.1016/j.tips.2006.01.005.
Costanzi S, Mamedova L, Gao ZG, Jacobson KA: Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. J Med Chem. 2004, 47: 5393-5404. 10.1021/jm049914c.
Afework M, Burnstock G: Changes in P2Y2 receptor localization on adrenaline- and noradrenaline-containing chromaffin cells in the rat adrenal gland during development and aging. Int J Dev Neurosci. 2005, 23: 567-573. 10.1016/j.ijdevneu.2005.07.004.
Laitinen JT, Uri A, Raidaru G, Miettinen R: [(35)S]GTPgammaS autoradiography reveals a wide distribution of G(i/o)-linked ADP receptors in the nervous system: close similarities with the platelet P2Y(ADP) receptor. J Neurochem. 2001, 77: 505-518. 10.1046/j.1471-4159.2001.00265.x.
Burnstock G: Purine and pyrimidine receptors. Cell Mol Life Sci. 2007
Dunn PM, Zhong Y, Burnstock G: P2X receptors in peripheral neurons. Prog Neurobiol. 2001, 65: 107-134. 10.1016/S0301-0082(01)00005-3.
Liu M, Dunn PM, King BF, Burnstock G: Rat chromaffin cells lack P2X receptors while those of the guinea-pig express a P2X receptor with novel pharmacology. Br J Pharmacol. 1999, 128: 61-68. 10.1038/sj.bjp.0702790.
Otsuguro K, Asano T, Ohta T, Ito S, Nakazato Y: ATP-evoked membrane current in guinea pig adrenal chromaffin cells. Neurosci Lett. 1995, 187: 145-148. 10.1016/0304-3940(95)11359-5.
Tomé AR, Castro E, Santos RM, Rosário LM: Selective stimulation of catecholamine release from bovine adrenal chromaffin cells by an ionotropic purinergic receptor sensitive to 2-methylthio ATP. BMC Neurosci. 2007, 8 (1): 41-10.1186/1471-2202-8-41.
Burgoyne RD: Mechanisms of secretion from adrenal chromaffin cells. Biochim Biophys Acta. 1984, 779: 201-216.
North RA: Molecular physiology of P2X receptors. Physiol Rev. 2002, 82: 1013-1067.
Burnstock G: Purinergic signalling--an overview. Novartis Found Symp. 2006, 276: 26-48; discussion 48-57, 275-81..
Illes P, Ribeiro JA: Neuronal P2 receptors of the central nervous system. Curr Top Med Chem. 2004, 4: 831-838. 10.2174/1568026043451032.
Chen XK, Wang LC, Zhou Y, Cai Q, Prakriya M, Duan KL, Sheng ZH, Lingle C, Zhou Z: Activation of GPCRs modulates quantal size in chromaffin cells through G(betagamma) and PKC. Nat Neurosci. 2005, 8: 1160-1168. 10.1038/nn1529.
Baldelli P, Hernandez-Guijo JM, Carabelli V, Novara M, Cesetti T, ndres-Mateos E, Montiel C, Carbone E: Direct and remote modulation of L-channels in chromaffin cells: distinct actions on alpha1C and alpha1D subunits?. Mol Neurobiol. 2004, 29: 73-96. 10.1385/MN:29:1:73.
Carabelli V, Carra I, Carbone E: Localized secretion of ATP and opioids revealed through single Ca2+ channel modulation in bovine chromaffin cells. Neuron. 1998, 20: 1255-1268. 10.1016/S0896-6273(00)80505-X.
Hernandez-Guijo JM, Carabelli V, Gandia L, Garcia AG, Carbone E: Voltage-independent autocrine modulation of L-type channels mediated by ATP, opioids and catecholamines in rat chromaffin cells. Eur J Neurosci. 1999, 11: 3574-3584. 10.1046/j.1460-9568.1999.00775.x.
Ohta T, Kai T, Ito S: Evidence for paracrine modulation of voltage-dependent calcium channels by amperometric analysis in cultured porcine adrenal chromaffin cells. Brain Res. 2004, 1030: 183-192. 10.1016/j.brainres.2004.10.006.
Kitamura G, Ohta T, Kai T, Kon Y, Ito S: Inhibitory effects of opioids on voltage-dependent Ca(2+) channels and catecholamine secretion in cultured porcine adrenal chromaffin cells. Brain Res. 2002, 942: 11-22. 10.1016/S0006-8993(02)02648-3.
Kleppisch T, hnert-Hilger G, Gollasch M, Spicher K, Hescheler J, Schultz G, Rosenthal W: Inhibition of voltage-dependent Ca2+ channels via alpha 2-adrenergic and opioid receptors in cultured bovine adrenal chromaffin cells. Pflugers Arch. 1992, 421: 131-137. 10.1007/BF00374819.
Brede M, Nagy G, Philipp M, Sorensen JB, Lohse MJ, Hein L: Differential control of adrenal and sympathetic catecholamine release by alpha 2-adrenoceptor subtypes. Mol Endocrinol. 2003, 17: 1640-1646. 10.1210/me.2003-0035.
Sena CM, Santos RM, Standen NB, Boarder MR, Rosario LM: Isoform-specific inhibition of voltage-sensitive Ca(2+) channels by protein kinase C in adrenal chromaffin cells. FEBS Lett. 2001, 492: 146-150. 10.1016/S0014-5793(01)02252-9.
Robinson IM, Finnegan JM, Monck JR, Wightman RM, Fernandez JM: Colocalization of calcium entry and exocytotic release sites in adrenal chromaffin cells. Proc Natl Acad Sci U S A. 1995, 92: 2474-2478. 10.1073/pnas.92.7.2474.
Chern YJ, Bott M, Chu PJ, Lin YJ, Kao LS, Westhead EW: The adenosine analogue N6-L-phenylisopropyladenosine inhibits catecholamine secretion from bovine adrenal medulla cells by inhibiting calcium influx. J Neurochem. 1992, 59: 1399-1404. 10.1111/j.1471-4159.1992.tb08453.x.
Rosario LM, Soria B, Feuerstein G, Pollard HB: Voltage-sensitive calcium flux into bovine chromaffin cells occurs through dihydropyridine-sensitive and dihydropyridine- and omega-conotoxin-insensitive pathways. Neuroscience. 1989, 29: 735-747. 10.1016/0306-4522(89)90145-0.
Rosario LM, Stutzin A, Cragoe EJ, Pollard HB: Modulation of intracellular pH by secretagogues and the Na+/H+ antiporter in cultured bovine chromaffin cells. Neuroscience. 1991, 41: 269-276. 10.1016/0306-4522(91)90215-A.
Marks PW, Maxfield FR: Preparation of solutions with free calcium concentration in the nanomolar range using 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid. Anal Biochem. 1991, 193: 61-71. 10.1016/0003-2697(91)90044-T.
Grynkiewicz G, Poenie M, Tsien RY: A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985, 260: 3440-3450.
Minta A, Tsien RY: Fluorescent indicators for cytosolic sodium. J Biol Chem. 1989, 264: 19449-19457.
Information Technology Laboratory - National Institute of Standards and Technology. [http://www.itl.nist.gov]
This work was partially financed by a grant from FCT (Fundação para a Ciência e a Tecnologia, Portugal). Dr. E. Castro was supported by a FEBS fellowship. The facilities provided by the Faculty of Medicine (University of Coimbra) are gratefully acknowledged.
ART carried out the experiments, performed the statistical analysis, prepared the figures, participated in conceiving and designing the study, and helped to draft the manuscript; EC helped in carrying out the experiments and participated in conceiving and designing the study; RMS helped to draft the manuscript; LMR participated in conceiving and coordinating the study and drafted the manuscript. All authors read and approved the final manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Tomé, Â.R., Castro, E., Santos, R.M. et al. Functional distribution of Ca2+-coupled P2 purinergic receptors among adrenergic and noradrenergic bovine adrenal chromaffin cells. BMC Neurosci 8, 39 (2007). https://0-doi-org.brum.beds.ac.uk/10.1186/1471-2202-8-39
- Tyrosine Hydroxylase
- Chromaffin Cell
- Virtual Absence
- Bovine Chromaffin Cell
- Frequency Distribution Histogram